• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁丙诺啡/纳洛酮复方片剂在高处方流行地区的转移。

Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence.

机构信息

University of Massachusetts Medical School, Worcester, MA, USA.

出版信息

J Addict Dis. 2009 Jul;28(3):226-31. doi: 10.1080/10550880903014767.

DOI:10.1080/10550880903014767
PMID:20155591
Abstract

The purpose of this article was to characterize practices of buprenorphine/naloxone (B/N) diversion in a region with a high prescribing prevalence. A cross-sectional, open-ended survey was administered to individuals entering opioid addiction treatment programs in two New England states. The authors obtained formative information about the knowledge, attitudes, beliefs, practices, and street economy of B/N diversion. The authors interviewed 51 individuals, 49 of which were aware of B/N medication. Of that number, 100% had diverted B/N to modulate opiate withdrawal symptoms arising from attempted "self-detoxification," insufficient funds to purchase preferred illicit opioids, or inability to find a preferred source of drugs. Thirty of 49 (61%) participants obtained the illicit drug from an individual holding a legitimate prescription for B/N. A high proportion of individuals in the study locations who sought treatment for opioid addiction self-reported the purchase and use of diverted B/N. The diversion of B/N may be minimized by modifying educational, treatment, monitoring, and dispensing practices.

摘要

本文旨在描述一个高处方流行地区丁丙诺啡/纳洛酮(B/N)转用的情况。在两个新英格兰州的阿片类药物成瘾治疗项目中,对进入项目的个人进行了横断面、开放式调查。作者获得了关于 B/N 转用的知识、态度、信念、实践和街头经济的形成性信息。作者采访了 51 人,其中 49 人了解 B/N 药物。在这一数字中,100%的人曾将 B/N 转用,以调节因试图“自我戒毒”、资金不足购买首选非法阿片类药物或无法找到首选毒品来源而引起的阿片类药物戒断症状。在研究地点,49 名参与者中有 30 名(61%)从持有 B/N 合法处方的个人那里获得了非法药物。寻求阿片类药物成瘾治疗的研究地点的个人中有很大一部分自我报告购买和使用了转用的 B/N。通过修改教育、治疗、监测和配药实践,可以最大限度地减少 B/N 的转用。

相似文献

1
Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence.丁丙诺啡/纳洛酮复方片剂在高处方流行地区的转移。
J Addict Dis. 2009 Jul;28(3):226-31. doi: 10.1080/10550880903014767.
2
The diversion and injection of a buprenorphine-naloxone soluble film formulation.丁丙诺啡-纳洛酮可溶膜制剂的转移与注射
Drug Alcohol Depend. 2014 Mar 1;136:21-7. doi: 10.1016/j.drugalcdep.2013.12.005. Epub 2014 Jan 8.
3
Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting.在意大利,双相丁丙诺啡/纳洛酮每两周一次与丁丙诺啡的临床经验:基于诊所有初步观察数据。
Clin Drug Investig. 2010;30 Suppl 1:33-9. doi: 10.2165/11536060-000000000-00000.
4
The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia.澳大利亚社区药房配药费对丁丙诺啡-纳洛酮引入的影响。
Drug Alcohol Rev. 2007 Jul;26(4):411-6. doi: 10.1080/09595230701373891.
5
Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.丁丙诺啡 - 纳洛酮片在未经治疗的静脉吸毒者中的滥用倾向
Drug Alcohol Depend. 2007 Apr 17;88(1):75-8. doi: 10.1016/j.drugalcdep.2006.09.012. Epub 2006 Oct 19.
6
Diffusion and diversion of suboxone: an exploration of illicit street opioid selling.
J Addict Dis. 2014;33(3):177-86. doi: 10.1080/10550887.2014.950030.
7
New pharmacological tool approved for opioid addiction.用于阿片类药物成瘾的新型药理学工具获批。
HIV Clin. 2004 Summer;16(3):9-11.
8
The More Things Change: Buprenorphine/naloxone Diversion Continues While Treatment Remains Inaccessible.世事变迁:丁丙诺啡/纳洛酮仍在被转移,而治疗却仍难以获得。
J Addict Med. 2018 Nov/Dec;12(6):459-465. doi: 10.1097/ADM.0000000000000436.
9
The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia.澳大利亚阿片类物质替代治疗(OST)患者中丁丙诺啡吸入的流行率及相关因素。
Int J Drug Policy. 2011 Mar;22(2):167-71. doi: 10.1016/j.drugpo.2010.10.004. Epub 2010 Nov 27.
10
The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001-03.英格兰丁丙诺啡处方量的增长:2001 - 2003年国民健康服务体系区域数据分析
Addiction. 2005 Apr;100(4):495-9. doi: 10.1111/j.1360-0443.2005.01039.x.

引用本文的文献

1
Analysis of Drugs in Saliva of US Military Veterans Treated for Substance Use Disorders Using Supported Liquid Extraction and Surface-Enhanced Raman Spectral Analysis.应用支持液提取和表面增强拉曼光谱分析对接受物质使用障碍治疗的美国退伍军人唾液中药物的分析。
Molecules. 2023 Feb 21;28(5):2010. doi: 10.3390/molecules28052010.
2
Trajectories of non-prescribed buprenorphine and other opioid use: A multi-trajectory latent class growth analysis.非处方丁丙诺啡和其他阿片类药物使用轨迹:多轨迹潜在类别增长分析。
J Subst Use Addict Treat. 2023 Apr;147:208973. doi: 10.1016/j.josat.2023.208973. Epub 2023 Feb 10.
3
Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States: A Scoping Review.
美国丁丙诺啡转用的范围、动机和结果:范围综述。
Subst Use Misuse. 2023;58(5):685-697. doi: 10.1080/10826084.2023.2177972. Epub 2023 Feb 20.
4
Changes in Buprenorphine Treatment After Medicaid Expansion.医疗补助扩大后丁丙诺啡治疗的变化。
Psychiatr Serv. 2021 Jun;72(6):633-640. doi: 10.1176/appi.ps.202000491. Epub 2021 Mar 18.
5
Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatment.急诊部门未治疗的阿片类药物使用障碍患者:寻求与不寻求药物使用治疗转诊的比较。
Drug Alcohol Depend. 2021 Feb 1;219:108428. doi: 10.1016/j.drugalcdep.2020.108428. Epub 2020 Nov 26.
6
Types of Medication-Assisted Treatment for Opioid Use Disorder in Turkey: The Perceptions of Inpatients about Treatment Success.土耳其阿片类物质使用障碍药物辅助治疗的类型:住院患者对治疗成功的看法
Psychiatry Investig. 2020 Dec;17(12):1182-1190. doi: 10.30773/pi.2020.0307. Epub 2020 Dec 11.
7
Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others.初级保健提供者、精神科医生、成瘾专家等提供的丁丙诺啡治疗。
Health Aff (Millwood). 2020 Jun;39(6):984-992. doi: 10.1377/hlthaff.2019.01622.
8
How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users.使用丁丙诺啡产品的动机与使用阿片类镇痛药的动机有何不同:来自娱乐性使用者互联网讨论的观察性研究证据。
JMIR Public Health Surveill. 2020 Mar 25;6(1):e16038. doi: 10.2196/16038.
9
On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine.按自己的条件:非处方丁丙诺啡自我治疗阿片类药物使用障碍的动机。
Drug Alcohol Depend. 2020 May 1;210:107958. doi: 10.1016/j.drugalcdep.2020.107958. Epub 2020 Mar 16.
10
Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs.阿片类药物戒断症状、频率和疼痛特征与注射吸毒者健康风险的相关性。
Drug Alcohol Depend. 2020 Jun 1;211:107932. doi: 10.1016/j.drugalcdep.2020.107932. Epub 2020 Mar 18.